NovioTech is an open innovation driven business dealing directly with top medical device manufacturers and industry standard organisations. NovioTech focuses on the development of Intellectual Property and applications from its IP. NovioTech has a close collaboration with the Radboud University Institute for Molecules and Materials (IMM).
Currently we have IP on (1) a new type of glucose sensor (patent pending) and (2) a novel (nano-) material (exclusive worldwide license agreement with the Radboud University, the Netherlands) and are performing our own research whereby we collaborate with several research institutes in the Netherlands and Germany. Both related technologies are technology platforms with a wide range of applications. E.g. the sensor principle of the glucose sensor can be applied for the detection of other biomarkers.